Deka Bank Deutsche Girozentrale Voyager Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$6.0 - $10.78 $300,000 - $539,000	50,000 New	50,000 $380,000
Q2 2021 Aug 05, 2021	SELL	$3.94 - $5.44 $37,430 - $51,680	-9,500 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$10.01 - $13.75 $95,095 - $130,625	9,500 New	9,500 $104,000
Q3 2019 Nov 14, 2019	SELL	$16.31 - $28.29 $322,938 - $560,142	-19,800 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$19.18 - $27.88 $147,686 - $214,676	7,700 Added 63.64%	19,800 $521,000
Q1 2019 May 10, 2019	BUY	$8.0 - $19.66 $17,600 - $43,252	2,200 Added 22.22%	12,100 $259,000
Q4 2018 Feb 12, 2019	SELL	$8.59 - $18.05 $18,898 - $39,710	-2,200 Reduced 18.18%	9,900 $89,000
Q3 2018 Nov 09, 2018	SELL	$17.11 - $21.74 $5,133 - $6,521	-300 Reduced 2.42%	12,100 $0
Q1 2018 May 03, 2018	BUY	$16.16 - $31.31 $200,384 - $388,244	12,400 New	12,400 $227,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.